In these acute challenge models, such as is also produced by high dose LPS injection, MRP8/14 was suggested to act as a danger signal enhancing the cytokine response of LPS via TLR4, thereby potentiating the harmful systemic inflammatory response syndrome [15], [16]. The gene discussed is TLR4; the disease is systemic inflammatory response syndrome.